4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-26-044293
Director sold 10,000 shares at $13.92 ($139,200)
- Director acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Guiheen Lawrence P. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 1 in the form | +10,000 | $5.00 | $50,000 | 73,599 | D |
| 2026-11-16 | Sale : show line 2 in the form | −10,000 | $13.92 | $139,200 | 63,599 | D |
| Open-market sales · 10,000 sh · avg $13.92 · $139,200 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-16 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −10,000 | 0 | D |
Loading xslF345X06/form4.xml…